{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:09:24Z","timestamp":1774314564189,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.es","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jdcr.2025.12.040","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:26:58Z","timestamp":1767025618000},"page":"74-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report"],"prefix":"10.1016","volume":"69","author":[{"given":"Kasey","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jdcr.2025.12.040_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","article-title":"Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment","volume":"90","author":"Lehmann","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jdcr.2025.12.040_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/trf.12922","article-title":"Anti-SSA antibodies are present in immunoglobulin preparations","volume":"55","author":"van der Molen","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jdcr.2025.12.040_bib3","article-title":"Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature","volume":"11","author":"Khorasanchi","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.jdcr.2025.12.040_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1468-3083.2008.02806.x","article-title":"Pathogenesis of subacute cutaneous lupus erythematosus","volume":"22","author":"Stavropoulos","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.12.040_bib5","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1111\/1346-8138.17553","article-title":"Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis","volume":"52","author":"Alhassan","year":"2025","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.040_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jns.12218","article-title":"Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series","volume":"22","author":"Adrichem","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.jdcr.2025.12.040_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2019.02.009","article-title":"Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study","volume":"81","author":"Guicciardi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.040_bib8","article-title":"Drug-induced subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin during the treatment of Castleman disease\u2013associated paraneoplastic pemphigus","volume":"79","author":"Hoss","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.040_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.040_bib10","first-page":"203","article-title":"[Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sj\u00f6gren syndrome: a case report]","volume":"46","author":"Hatano","year":"2006","journal-title":"Rinsho Shinkeigaku"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625007404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625007404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:25:02Z","timestamp":1773728702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625007404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"alternative-id":["S2352512625007404"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.12.040","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}